Medpace
MEDP
422 hedge funds and large institutions have $5.04B invested in Medpace in 2022 Q4 according to their latest regulatory filings, with 95 funds opening new positions, 113 increasing their positions, 165 reducing their positions, and 26 closing their positions.
265% more first-time investments, than exits
New positions opened: 95 | Existing positions closed: 26
60% more funds holding in top 10
Funds holding in top 10: 5 → 8 (+3)
24% more capital invested
Capital invested by funds: $4.07B → $5.04B (+$971M)
18% more funds holding
Funds holding: 357 → 422 (+65)
5.3% less ownership
Funds ownership: 83.49% → 78.19% (-5.3%)
32% less repeat investments, than reductions
Existing positions increased: 113 | Existing positions reduced: 165
32% less call options, than puts
Call options by funds: $8.98M | Put options by funds: $13.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$48.5M |
| 2 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$43.7M |
| 3 |
BlackRock
New York
|
+$27.2M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$25.8M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$25.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$103M |
| 2 |
ESCM
Echo Street Capital Management
New York
|
-$95.9M |
| 3 |
VVP
Vulcan Value Partners
Birmingham,
Alabama
|
-$49.5M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$45.1M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
-$32.8M |
MEDP Hedge Fund Activity: Q4 2022 in Review
422 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q4 2022, worth a combined $5.04B — up 24% from $4.07B a quarter earlier.
Buyers outnumbered sellers: 95 funds opened new MEDP positions and 26 closed out — a net gain of 69 holders — while 113 added to existing stakes and 165 trimmed.
The largest buyer was Millennium Management, adding an estimated $48.5M. The largest seller was Wasatch Advisors, cutting an estimated $103M.
- 422 institutional investors held Medpace (MEDP) as of Q4 2022, up from 357 in Q3 2022.
- Funds reported $5.04B of Medpace stock for Q4 2022, up 24% quarter-over-quarter.
- 95 funds opened new Medpace positions in Q4 2022 and 26 closed out, a net change of +69 holders.
- The largest Medpace buyer in Q4 2022 was Millennium Management, an estimated $48.5M added.
- The largest Medpace seller in Q4 2022 was Wasatch Advisors, an estimated $103M sold.
Based on aggregated 13F filings for Q4 2022.